The Board of Directors of Aurinia Pharmaceuticals Inc. has authorized a buyback plan on February 15, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.815 USD | +0.95% | +16.43% | -34.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.98% | 822M | |
+9.51% | 115B | |
+11.92% | 106B | |
-3.03% | 21.96B | |
-14.25% | 21.87B | |
-5.29% | 19.21B | |
-3.88% | 18.08B | |
-38.29% | 17.71B | |
+6.64% | 14.32B | |
+35.21% | 12.42B |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- Aurinia Pharmaceuticals Inc. authorizes a Buyback Plan.